Stay updated on Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision label (v3.6.4) was added to the history, replacing the previous v3.6.3 label. This reflects an update to the page's revision metadata rather than changes to the study content.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe revision label in the page footer changed to v3.6.3, indicating a minor site build update rather than a content change.SummaryDifference0.0%

- Check39 days agoChange DetectedAn administrative revision entry (v3.6.2) was added to the study history and an older revision (v3.6.0) was removed, reflecting metadata maintenance of the record.SummaryDifference0.2%

- Check53 days agoChange DetectedRecruitment status was updated to no longer looking for participants, indicating enrollment is closed for this study. The record version was updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check61 days agoChange DetectedRevision: v3.5.5 appears as the latest entry on the history page, replacing the previous v3.5.4 entry. The history is updated to reflect the most recent release.SummaryDifference0.0%

- Check82 days agoChange DetectedThe record history now shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a new version of the page was published.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.